SINTX TECHNOLOGIES INC (SINT)
US8293927039 - Common Stock
Overall SINT gets a fundamental rating of 3 out of 10. We evaluated SINT against 188 industry peers in the Health Care Equipment & Supplies industry. SINT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SINT is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SINT has reported negative net income.
SINT had a negative operating cash flow in the past year.
SINT had negative earnings in each of the past 5 years.
SINT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
SINT's Return On Assets of -103.07% is on the low side compared to the rest of the industry. SINT is outperformed by 83.96% of its industry peers.
SINT has a worse Return On Equity (-208.74%) than 79.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.07% | ||
| ROE | -208.74% | ||
| ROIC | N/A |
ROA(3y)-67.03%
ROA(5y)-67.52%
ROE(3y)-145.89%
ROE(5y)-129.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SINT's Gross Margin of 66.06% is fine compared to the rest of the industry. SINT outperforms 69.52% of its industry peers.
SINT's Gross Margin has improved in the last couple of years.
SINT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y51.86%
GM growth 5Y11.31%
2. Health
2.1 Basic Checks
SINT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SINT has been increased compared to 1 year ago.
The number of shares outstanding for SINT has been increased compared to 5 years ago.
SINT has a better debt/assets ratio than last year.
2.2 Solvency
SINT has an Altman-Z score of -36.63. This is a bad value and indicates that SINT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -36.63, SINT is doing worse than 90.37% of the companies in the same industry.
SINT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -36.63 |
ROIC/WACCN/A
WACC8.89%
2.3 Liquidity
SINT has a Current Ratio of 3.04. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
SINT's Current ratio of 3.04 is in line compared to the rest of the industry. SINT outperforms 54.01% of its industry peers.
SINT has a Quick Ratio of 2.82. This indicates that SINT is financially healthy and has no problem in meeting its short term obligations.
SINT's Quick ratio of 2.82 is fine compared to the rest of the industry. SINT outperforms 60.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.04 | ||
| Quick Ratio | 2.82 |
3. Growth
3.1 Past
SINT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 94.65%, which is quite impressive.
The Revenue has grown by 30.40% in the past year. This is a very strong growth!
Measured over the past years, SINT shows a very strong growth in Revenue. The Revenue has been growing by 94.24% on average per year.
EPS 1Y (TTM)94.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%95.42%
Revenue 1Y (TTM)30.4%
Revenue growth 3Y64.14%
Revenue growth 5Y94.24%
Sales Q2Q%17.85%
3.2 Future
The Earnings Per Share is expected to grow by 40.84% on average over the next years. This is a very strong growth
SINT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.58% yearly.
EPS Next Y97.31%
EPS Next 2Y40.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.8%
Revenue Next 2Y17.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
SINT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SINT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SINT's earnings are expected to grow with 40.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.84%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SINT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SINTX TECHNOLOGIES INC
NASDAQ:SINT (11/21/2024, 4:24:26 PM)
After market: 4.28 -0.02 (-0.47%)4.3
+0.58 (+15.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.23M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -103.07% | ||
| ROE | -208.74% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.06% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.04 | ||
| Quick Ratio | 2.82 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)94.65%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y97.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)30.4%
Revenue growth 3Y64.14%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y